Virtual Trial models bring clinical research directly to patients to reduce burdens and improve engagement. These innovative models offer operational flexibility to better meet the unique needs of a trial and its key stakeholders.
In this webinar, we will discuss:
- How early adopter studies are applying virtual trial models in different ways to achieve more rapid patient enrollment, higher retention, better data quality and overall faster cycle times.
- Lessons learned from different types of virtual trials – from 100% virtual to hybrid models blending remote and site-based visits.
- How the regulatory environment is evolving to respond to virtual trials, and how early planning can support a sponsor's long-term success.
Hosted by Pharma Voice
Sponsored by IQVIA
Jessica Perry, Director of Virtual Site Operations at IQVIA – session chair
Dr. Lindsay McNair, MD, MPH, MSB, Chief Medical Officer, WIRB - Copernicus Group (WCG)
Abby Doctolero, Clinical Operations, Pear Therapeutics